1118 related articles for article (PubMed ID: 8403503)
1. Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease.
Reinecker HC; Steffen M; Witthoeft T; Pflueger I; Schreiber S; MacDermott RP; Raedler A
Clin Exp Immunol; 1993 Oct; 94(1):174-81. PubMed ID: 8403503
[TBL] [Abstract][Full Text] [Related]
2. Mucosal inflammatory cytokine production by intestinal biopsies in patients with ulcerative colitis and Crohn's disease.
Reimund JM; Wittersheim C; Dumont S; Muller CD; Baumann R; Poindron P; Duclos B
J Clin Immunol; 1996 May; 16(3):144-50. PubMed ID: 8734357
[TBL] [Abstract][Full Text] [Related]
3. Increased production of matrix metalloproteinase-3 and tissue inhibitor of metalloproteinase-1 by inflamed mucosa in inflammatory bowel disease.
Louis E; Ribbens C; Godon A; Franchimont D; De Groote D; Hardy N; Boniver J; Belaiche J; Malaise M
Clin Exp Immunol; 2000 May; 120(2):241-6. PubMed ID: 10792371
[TBL] [Abstract][Full Text] [Related]
4. Secretion imbalance between tumour necrosis factor and its inhibitor in inflammatory bowel disease.
Noguchi M; Hiwatashi N; Liu Z; Toyota T
Gut; 1998 Aug; 43(2):203-9. PubMed ID: 10189845
[TBL] [Abstract][Full Text] [Related]
5. Increased spontaneous secretion of rheumatoid factor by intestinal lamina propria mononuclear cells from Crohn's disease but not ulcerative colitis patients.
MacDermott RP; Schreiber S; Nash GS; Koopman WJ
Clin Exp Immunol; 1993 Apr; 92(1):152-7. PubMed ID: 8467559
[TBL] [Abstract][Full Text] [Related]
6. Immunoregulatory role of interleukin 10 in patients with inflammatory bowel disease.
Schreiber S; Heinig T; Thiele HG; Raedler A
Gastroenterology; 1995 May; 108(5):1434-44. PubMed ID: 7729636
[TBL] [Abstract][Full Text] [Related]
7. Immunoregulatory properties of IL-13 in patients with inflammatory bowel disease; comparison with IL-4 and IL-10.
Kucharzik T; Lügering N; Weigelt H; Adolf M; Domschke W; Stoll R
Clin Exp Immunol; 1996 Jun; 104(3):483-90. PubMed ID: 9099934
[TBL] [Abstract][Full Text] [Related]
8. Increased expression of interleukin-12 receptor beta(2) on lamina propria mononuclear cells of patients with active Crohn's disease.
Stallmach A; Marth T; Adrian N; Wittig BM; Ecker KW; Schilling M; Zeitz M
Int J Colorectal Dis; 2002 Sep; 17(5):303-10. PubMed ID: 12172923
[TBL] [Abstract][Full Text] [Related]
9. Thalidomide reduces tumour necrosis factor alpha and interleukin 12 production in patients with chronic active Crohn's disease.
Bauditz J; Wedel S; Lochs H
Gut; 2002 Feb; 50(2):196-200. PubMed ID: 11788559
[TBL] [Abstract][Full Text] [Related]
10. Increased in vitro release of soluble interleukin 2 receptor by colonic lamina propria mononuclear cells in inflammatory bowel disease.
Schreiber S; Raedler A; Conn AR; Rombeau JL; MacDermott RP
Gut; 1992 Feb; 33(2):236-41. PubMed ID: 1541420
[TBL] [Abstract][Full Text] [Related]
11. Crohn's disease, ulcerative colitis, and normal intestinal lymphocytes express integrins in dissimilar patterns.
Yacyshyn BR; Lazarovits A; Tsai V; Matejko K
Gastroenterology; 1994 Nov; 107(5):1364-71. PubMed ID: 7523224
[TBL] [Abstract][Full Text] [Related]
12. Peripheral blood monocyte cytokine production and acute phase response in inflammatory bowel disease.
Mazlam MZ; Hodgson HJ
Gut; 1992 Jun; 33(6):773-8. PubMed ID: 1624158
[TBL] [Abstract][Full Text] [Related]
13. In vitro effects of oxpentifylline on inflammatory cytokine release in patients with inflammatory bowel disease.
Reimund JM; Dumont S; Muller CD; Kenney JS; Kedinger M; Baumann R; Poindron P; Duclos B
Gut; 1997 Apr; 40(4):475-80. PubMed ID: 9176074
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-2 production in pediatric inflammatory bowel disease: evidence for dissimilar mononuclear cell function in Crohn's disease and ulcerative colitis.
Gurbindo C; Sabbah S; Menezes J; Justinich C; Marchand R; Seidman EG
J Pediatr Gastroenterol Nutr; 1993 Oct; 17(3):247-54. PubMed ID: 8271122
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical localization of vascular endothelial growth factor in colonic mucosa of patients with inflammatory bowel disease.
Griga T; May B; Pfisterer O; Müller KM; Brasch F
Hepatogastroenterology; 2002; 49(43):116-23. PubMed ID: 11941933
[TBL] [Abstract][Full Text] [Related]
16. Quantitative PCR analysis of TNF-alpha and IL-1 beta mRNA levels in pediatric IBD mucosal biopsies.
Dionne S; Hiscott J; D'Agata I; Duhaime A; Seidman EG
Dig Dis Sci; 1997 Jul; 42(7):1557-66. PubMed ID: 9246063
[TBL] [Abstract][Full Text] [Related]
17. Local and systemic liberation of proinflammatory cytokines in ulcerative colitis.
Gotteland M; Lopez M; Muñoz C; Saez R; Altshiller H; Llorens P; Brunser O
Dig Dis Sci; 1999 Apr; 44(4):830-5. PubMed ID: 10219845
[TBL] [Abstract][Full Text] [Related]
18. Differences in cytokine secretion by intestinal mononuclear cells, peripheral blood monocytes and alveolar macrophages from HIV-infected patients.
Steffen M; Reinecker HC; Petersen J; Doehn C; Pflüger I; Voss A; Raedler A
Clin Exp Immunol; 1993 Jan; 91(1):30-6. PubMed ID: 8419083
[TBL] [Abstract][Full Text] [Related]
19. Antioxidants inhibit the in vitro production of inflammatory cytokines in Crohn's disease and ulcerative colitis.
Reimund JM; Allison AC; Muller CD; Dumont S; Kenney JS; Baumann R; Duclos B; Poindron P
Eur J Clin Invest; 1998 Feb; 28(2):145-50. PubMed ID: 9541129
[TBL] [Abstract][Full Text] [Related]
20. Interleukin 8 secretion by colonic crypt cells in vitro: response to injury suppressed by butyrate and enhanced in inflammatory bowel disease.
Gibson P; Rosella O
Gut; 1995 Oct; 37(4):536-43. PubMed ID: 7489942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
